241 related articles for article (PubMed ID: 36133303)
1. Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study.
Wang JW; Jin CH; Ke JF; Ma YL; Wang YJ; Lu JX; Li MF; Li LX
Front Endocrinol (Lausanne); 2022; 13():942412. PubMed ID: 36133303
[TBL] [Abstract][Full Text] [Related]
2. GA/HbA1c ratio is a simple and practical indicator to evaluate the risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: an observational study.
Wang JW; Jin CH; Ke JF; Ma YL; Wang YJ; Lu JX; Li MF; Li LX
Diabetol Metab Syndr; 2022 Nov; 14(1):167. PubMed ID: 36369095
[TBL] [Abstract][Full Text] [Related]
3. Blood lactate levels are associated with an increased risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: a real-world study.
Ma YL; Ke JF; Wang JW; Wang YJ; Xu MR; Li LX
Front Endocrinol (Lausanne); 2023; 14():1133991. PubMed ID: 37223022
[TBL] [Abstract][Full Text] [Related]
4. Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes.
Wang YJ; Jin CH; Ke JF; Wang JW; Ma YL; Lu JX; Li MF; Li LX
Diabetes Metab Syndr Obes; 2022; 15():3717-3728. PubMed ID: 36471670
[TBL] [Abstract][Full Text] [Related]
5. Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study.
Zhang ZH; Ke JF; Lu JX; Liu Y; Wang AP; Li LX
Diabetes Metab J; 2022 Jan; 46(1):129-139. PubMed ID: 34372627
[TBL] [Abstract][Full Text] [Related]
6. J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes.
Zhu C; Ma H; Huang D; Li G; Gao J; Cai M; You H; Bu L; Qu S
Front Endocrinol (Lausanne); 2022; 13():815995. PubMed ID: 35222274
[TBL] [Abstract][Full Text] [Related]
7. Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study.
Cui J; Liu Y; Li M; Yin J; Yang J; Xu L
BMC Endocr Disord; 2024 Mar; 24(1):27. PubMed ID: 38438865
[TBL] [Abstract][Full Text] [Related]
8. Monocyte to High-Density Lipoprotein Cholesterol Ratio at the Nexus of Type 2 Diabetes Mellitus Patients With Metabolic-Associated Fatty Liver Disease.
Jia J; Liu R; Wei W; Yu F; Yu X; Shen Y; Chen C; Cai Z; Wang C; Zhao Z; Wang D; Yang L; Yuan G
Front Physiol; 2021; 12():762242. PubMed ID: 34975521
[No Abstract] [Full Text] [Related]
9. Associations of sex-related and thyroid-related hormones with risk of metabolic dysfunction-associated fatty liver disease in T2DM patients.
Lu W; Li S; Li Y; Zhou J; Wang K; Chen N; Li Z
BMC Endocr Disord; 2024 Jun; 24(1):84. PubMed ID: 38849804
[TBL] [Abstract][Full Text] [Related]
10. Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease.
Su W; Chen M; Xiao L; Du S; Xue L; Feng R; Ye W
Front Public Health; 2022; 10():1047794. PubMed ID: 36420005
[TBL] [Abstract][Full Text] [Related]
11. Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction associated fatty liver disease in Chinese patients with type 2 diabetes mellitus.
Yang S; Xu J
J Diabetes Investig; 2024 May; 15(5):634-642. PubMed ID: 38251808
[TBL] [Abstract][Full Text] [Related]
12. [Associations between serum GDF15 and glycolipid metabolism disorder in metabolic associated fatty liver patients].
Li X; Yu XM; Li EH; Chen PH; Zheng LM; Zhang S
Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):987-992. PubMed ID: 37528037
[No Abstract] [Full Text] [Related]
13. Hyperuricemia as an independent risk factor for metabolic dysfunction-associated fatty liver disease in nonobese patients without type 2 diabetes mellitus.
Liu J; Wang C; Wang YT; Liu JX; Zhou TH; Yao SK; Chen G
Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E62-E71. PubMed ID: 37285598
[TBL] [Abstract][Full Text] [Related]
14. Association between Chinese visceral adiposity index and metabolic-associated fatty liver disease in Chinese adults with type 2 diabetes mellitus.
Tang M; Wei XH; Cao H; Zhen Q; Liu F; Wang YF; Fan NG; Peng YD
Front Endocrinol (Lausanne); 2022; 13():935980. PubMed ID: 35979441
[TBL] [Abstract][Full Text] [Related]
15. A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes.
Efrem IC; Moța M; Vladu IM; Mitrea A; Clenciu D; Timofticiuc DCP; Diaconu ID; Turcu A; Crișan AE; Geormăneanu C; Glodeanu AD; Mahler B; Tudor MS; Amzolini AM; Micu SE; Barău Abu Alhija A; Mită A; Filip MM; Forțofoiu M
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292115
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Is Associated with Cervical Stromal Involvement in Endometrial Cancer Patients: A Cross-Sectional Study in South China.
Lin X; Chen C; Jiang T; Ma J; Huang L; Huang L; Lei H; Tong Y; Huang G; Mao X; Sun P
Curr Oncol; 2023 Mar; 30(4):3787-3799. PubMed ID: 37185400
[TBL] [Abstract][Full Text] [Related]
17. Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes.
Mantovani A; Csermely A; Taverna A; Cappelli D; Benfari G; Bonapace S; Byrne CD; Targher G
Diabetes Metab; 2023 Mar; 49(2):101416. PubMed ID: 36586476
[TBL] [Abstract][Full Text] [Related]
18. Metabolic characteristics of non-obese and obese metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus and its association with diabetic peripheral neuropathy and diabetic retinopathy.
Dang SW; Gao L; Li YJ; Zhang R; Xu J
Front Med (Lausanne); 2023; 10():1216412. PubMed ID: 37828942
[TBL] [Abstract][Full Text] [Related]
19. Association of Uric Acid to Creatinine Ratio with Metabolic Dysfunction-Associated Fatty Liver in Non-Obese Individuals Without Type 2 Diabetes Mellitus.
Liu J; Wang C; Wang Y; Yao S
Diabetes Metab Syndr Obes; 2024; 17():131-142. PubMed ID: 38222031
[TBL] [Abstract][Full Text] [Related]
20. Association between complement C3 and the prevalence of metabolic-associated fatty liver disease in a Chinese population: a cross-sectional study.
Feng L; Zhao Y; Wang WL
BMJ Open; 2021 Oct; 11(10):e051218. PubMed ID: 34711595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
